Abstract:Rationale: Mxi1 is regarded as a potential tumor suppressor protein that antagonizes the transcriptional activity of proto-oncogene Myc. However, the clinical significances and underlying mechanisms by which Mxi1 is regulated in lung cancer remain poorly understood. Methods: Mass spectrometry analysis and immunoprecipitation assay were utilized to detect the protein-protein interaction. The phosphorylation of Mxi1 was evaluated by in vitro kinase assays. Poly-ubiquitination of Mxi1 was examined by in vivo ubiquitination assay. Lung cancer cells stably expressing wild-type Mxi1 or Mxi1-S160A were used for functional analyses. The expression levels of Mxi1 and S6K1 were determined by immunohistochemistry in lung cancer tissues and adjacent normal lung tissues. Results: We found that Mxi1 is downregulated and correlated with poor prognosis in lung cancer. Using tandem affinity purification technology, we provided evidence that β-Trcp E3 ubiquitin ligase interacts with and promotes the ubiquitination and degradation of Mxi1. Furthermore, we demonstrated that Mxi1 is phosphorylated at S160 site by the protein kinase S6K1 and subsequently degraded via the ubiquitin ligase β-Trcp. Moreover, a phosphorylation mutant form of Mxi1 (Mxi1-S160A), which cannot be degraded by S6K1 and β-Trcp, is much more stable and efficient in suppressing the transcriptional activity of Myc and radioresistance in lung cancer cells. More importantly, a strong inverse correlation between S6K1 and Mxi1 expression was observed in human lung cancer tissues. Conclusion: Our findings not only establish a crosstalk between the mTOR/S6K1 signaling pathway and Myc activation, but also suggest that targeting S6K1/Mxi1 pathway is a promising therapeutic strategy for the treatment of lung cancer.

Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15

MEKK2 and MEKK3 Suppress Hedgehog Pathway-Dependent Medulloblastoma by Inhibiting GLI1 Function

The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.

The E3 Ubiquitin Ligase Mule Acts Through the ATM–p53 Axis to Maintain B Lymphocyte Homeostasis

Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.

Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2.

The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair

RPL23 Links Oncogenic RAS Signaling to P53-Mediated Tumor Suppression

Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10

K48-linked KLF4 ubiquitination by E3 ligase Mule controls T-cell proliferation and cell cycle progression

Mule/ARF-BP1, a BH3-Only E3 Ubiquitin Ligase, Catalyzes the Polyubiquitination of Mcl-1 and Regulates Apoptosis

N-myc Alters the Fate of Preneoplastic Cells in a Mouse Model of Medulloblastoma.

PUMILIO proteins promote colorectal cancer growth via suppressing p21

The Antitumor Peptide M1-20 Induced the Degradation of CDK1 Through CUL4-DDB1-DCAF1-involved Ubiquitination.

ΔNp63α Down-Regulates C-Myc Modulator MM1 Via E3 Ligase HERC3 in the Regulation of Cell Senescence.

S6K1 Phosphorylation-Dependent Degradation of Mxi1 by Β-Trcp Ubiquitin Ligase Promotes Myc Activation and Radioresistance in Lung Cancer.

FoxM1c Counteracts Oxidative Stress-Induced Senescence in Mouse Embryonic Fibroblasts by Up-Regulation of Bmi-1 Expression

The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth

Impact of Mucin1 Knockdown on the Phenotypic Characteristics of the Human Hepatocellular Carcinoma Cell Line Smmc-7721

Targeted Polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP Ligases in Response to DNA Damage

MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A